Neuron Guard
THE NEW STANDARD OF CARE FOR THE TARGETED TEMPERATURE MANAGEMENT OF BRAIN DAMAGES
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Cambridge, UK
- Currency EUR
- Founded May 2013
- Employees 2
- Incorporation Type Other
- Website neuronguard.com
Company Summary
We are developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. The solution - patented in Italy, USA, China, New Zealand - is a therapeutic collar, covered by a protective shell and powered by a smart control unit (the size of a small briefcase). Our mission is to improve the safety of patients in hospitals and emergency situations, and reduce the costs of chronic care.
Team
-
CMO30years old, cofounder & CMO. She has a MD in Economics at LIUC – University Carlo Cattaneo and completed the MISA Program at SDA Bocconi School of Management. She has joined Neuron Guard in the early stage of its incubation because of her competence in the field of strategy and communication. She owned for two years a cooperative company active in the healthcare field, supplying a wide range of services to rehabilitation centers.
-
CEOA 33-years-old medical visionary, he is the founder of Neuron Guard and the creator of the integrated brain protection system. The deep knowledge of the field of Emergency Medicine and Intensive Care combined with creativity and dedication are the basis for the development of the company. Six out of ten years of Medical School and Residency at the University of Modena and Reggio Emilia have been dedicated to Anaesthesia and Intensive Care.
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.